Literature DB >> 24468092

Transcranial magnetic stimulation of the left dorsolateral prefrontal cortex decreases cue-induced nicotine craving and EEG delta power.

Jürgen Pripfl1, Livia Tomova2, Igor Riecansky3, Claus Lamm2.   

Abstract

BACKGROUND: TMS has high potential as smoking cessation treatment. However, the neural mechanisms underlying TMS induced reduction of tobacco craving remain unclear. Electroencephalographic (EEG) delta frequency has been associated with the activity of the dopaminergic brain reward system, which is crucial for nicotine induced effects, and decreases after nicotine admission in smokers.
OBJECTIVE: The aim of this study was to investigate EEG delta power changes induced by hf rTMS of the left dorsolateral prefrontal cortex (DLPFC) in nicotine deprived smokers and it's relation to cue-induced nicotine craving.
METHODS: Fourteen healthy smokers meeting ICD-10 criteria for tobacco addiction participated in this within-subject sham controlled study. Participants had to abstain from smoking 6 h before the experiment. Effects of high-frequency repetitive TMS (hf rTMS) (10 Hz) for verum (left DLPFC) and sham (vertex) stimulations on cue-induced nicotine craving and resting state EEG delta power were assessed before and three times within 40 min after rTMS.
RESULTS: Both craving (P = 0.046) and EEG delta power (P = 0.048) were significantly lower after verum stimulation compared to sham stimulation across the whole post stimulation time period assessed. However, changes of craving ratings and delta power did not correlate.
CONCLUSION: Hf rTMS applied to the left DLPFC reduces nicotine craving in short-term abstinent smokers. Changes in delta activity support the idea that stimulation induced effects are mediated by the dopaminergic brain reward system, which presumably plays a prominent, but probably not exclusive, role in this stimulation induced behavioral modulation, making this method a promising smoking cessation treatment candidate.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dorsolateral prefrontal cortex; Electroencephalography; Nicotine craving; Smoking cessation; Transcranial magnetic stimulation

Mesh:

Substances:

Year:  2013        PMID: 24468092     DOI: 10.1016/j.brs.2013.11.003

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  41 in total

Review 1.  Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research.

Authors:  Primavera A Spagnolo; David Goldman
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

Review 2.  Neuroimaging reward, craving, learning, and cognitive control in substance use disorders: review and implications for treatment.

Authors:  Jody Tanabe; Michael Regner; Joseph Sakai; Diana Martinez; Joshua Gowin
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

3.  The left dorsolateral prefrontal cortex and caudate pathway: New evidence for cue-induced craving of smokers.

Authors:  Kai Yuan; Dahua Yu; Yanzhi Bi; Ruonan Wang; Min Li; Yajuan Zhang; Minghao Dong; Jinquan Zhai; Yangding Li; Xiaoqi Lu; Jie Tian
Journal:  Hum Brain Mapp       Date:  2017-06-27       Impact factor: 5.038

Review 4.  Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development.

Authors:  Colleen A Hanlon; Logan T Dowdle; J Scott Henderson
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

5.  Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers.

Authors:  Xingbao Li; Lian Du; Gregory L Sahlem; Bashar W Badran; Scott Henderson; Mark S George
Journal:  Drug Alcohol Depend       Date:  2017-02-28       Impact factor: 4.492

6.  Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users.

Authors:  Gregory L Sahlem; Nathaniel L Baker; Mark S George; Robert J Malcolm; Aimee L McRae-Clark
Journal:  Am J Drug Alcohol Abuse       Date:  2017-08-14       Impact factor: 3.829

Review 7.  Neuroimaging the Effectiveness of Substance Use Disorder Treatments.

Authors:  Elizabeth A Cabrera; Corinde E Wiers; Elsa Lindgren; Gregg Miller; Nora D Volkow; Gene-Jack Wang
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-16       Impact factor: 4.147

Review 8.  Brain Stimulation in Addiction.

Authors:  Michael C Salling; Diana Martinez
Journal:  Neuropsychopharmacology       Date:  2016-05-31       Impact factor: 7.853

Review 9.  Functional Neurocircuits and Neuroimaging Biomarkers of Tobacco Use Disorder.

Authors:  Matthew T Sutherland; Elliot A Stein
Journal:  Trends Mol Med       Date:  2018-02       Impact factor: 11.951

Review 10.  Biomarkers for Success: Using Neuroimaging to Predict Relapse and Develop Brain Stimulation Treatments for Cocaine-Dependent Individuals.

Authors:  C A Hanlon; L T Dowdle; J L Jones
Journal:  Int Rev Neurobiol       Date:  2016-07-25       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.